Company / SG&A per Share
Entera Bio Ltd. SG&A per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.01
FY2025
5-year range
$0.01 / $0.25
FY2021-FY2025
Trend
-93.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.25 to $0.01 over the past 2 years.
Based on SEC 10-K filings.
0.01 in FY2025 with a 3-year CAGR of -64.6%.
Improved from $0.25 to $0.01 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -64.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 93.0% year-over-year.
- Peak sg&a per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -93.0% |
| FY2024 | $0.12 | -50.4% |
| FY2023 | $0.25 | +27.4% |
| FY2022 | $0.20 | -14.2% |
| FY2021 | $0.23 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026